106 related articles for article (PubMed ID: 28611038)
1. Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model.
Chandra S; Nymeyer AC; Rice PF; Gerner EW; Barton JK
Cancer Prev Res (Phila); 2017 Aug; 10(8):459-466. PubMed ID: 28611038
[TBL] [Abstract][Full Text] [Related]
2. Does Mutated
Rice PFS; Ehrichs KG; Jones MS; Chen H; Hsu CH; Abril ER; Nagle RB; Besselsen DG; Barton JK; Ignatenko NA
Cancer Prev Res (Phila); 2018 Jan; 11(1):16-26. PubMed ID: 29118162
[TBL] [Abstract][Full Text] [Related]
3. R-flurbiprofen suppresses distal nonmucin-producing colorectal tumors in azoxymethane-treated rats, without suppressing eicosanoid production.
Martin JE; Le Leu RK; Hu Y; Young GP
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G860-4. PubMed ID: 20338924
[TBL] [Abstract][Full Text] [Related]
4. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
[TBL] [Abstract][Full Text] [Related]
5. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
[TBL] [Abstract][Full Text] [Related]
6. Comparing the effects of COX and non-COX-inhibiting NSAIDs on enhancement of apoptosis and inhibition of aberrant crypt foci formation in a rat colorectal cancer model.
Martin JE; Young GP; LE Leu RK; Hu Y
Anticancer Res; 2013 Sep; 33(9):3581-8. PubMed ID: 24023283
[TBL] [Abstract][Full Text] [Related]
7. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
[TBL] [Abstract][Full Text] [Related]
8. Sulindac corrects defective apoptosis and suppresses azoxymethane-induced colonic oncogenesis in p53 knockout mice.
Hu Y; Le Leu RK; Young GP
Int J Cancer; 2005 Oct; 116(6):870-5. PubMed ID: 15849741
[TBL] [Abstract][Full Text] [Related]
9. MF tricyclic and sulindac retard tumor formation in an animal model.
Dvory-Sobol H; Kazanov D; Liberman E; Birkenfeld S; Bulvik B; Luk P; Leshno M; Arber N
Int J Cancer; 2006 Jan; 118(1):11-6. PubMed ID: 16003752
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS
Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention for colorectal tumorigenesis associated with chronic colitis in mice via apoptosis.
Orii S; Yamaguchi T; Anzai H; Saito S; Chiba T; Suzuki K
J Exp Clin Cancer Res; 2003 Mar; 22(1):41-6. PubMed ID: 12725321
[TBL] [Abstract][Full Text] [Related]
12. Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development.
Davis JS; Kanikarla-Marie P; Gagea M; Yu PL; Fang D; Sebastian M; Yang P; Hawk E; Dashwood R; Lichtenberger LM; Menter D; Kopetz S
BMC Cancer; 2020 Sep; 20(1):871. PubMed ID: 32912193
[TBL] [Abstract][Full Text] [Related]
13. Defective acute apoptotic response to genotoxic carcinogen in small intestine of APC(Min/+) mice is restored by sulindac.
Hu Y; Le Leu RK; Young GP
Cancer Lett; 2007 Apr; 248(2):234-44. PubMed ID: 16950562
[TBL] [Abstract][Full Text] [Related]
14. Paricalcitol Enhances the Chemopreventive Efficacy of 5-Fluorouracil on an Intermediate-Term Model of Azoxymethane-Induced Colorectal Tumors in Rats.
El-Shemi AG; Refaat B; Kensara OA; Mohamed AM; Idris S; Ahmad J
Cancer Prev Res (Phila); 2016 Jun; 9(6):491-501. PubMed ID: 27020656
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the anti-proliferation and apoptosis-induction activities of sulindac, celecoxib, curcumin, and nifedipine in mismatch repair-deficient cell lines.
Wei SC; Lin YS; Tsao PN; Wu-Tsai JJ; Wu CH; Wong JM
J Formos Med Assoc; 2004 Aug; 103(8):599-606. PubMed ID: 15340658
[TBL] [Abstract][Full Text] [Related]
16. Sulindac modulates secreted protein expression from LIM1215 colon carcinoma cells prior to apoptosis.
Greening DW; Ji H; Kapp EA; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2293-307. PubMed ID: 23899461
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive Properties and Toxicity of Kelulut Honey in Sprague Dawley Rats Induced with Azoxymethane.
Saiful Yazan L; Muhamad Zali MF; Mohd Ali R; Zainal NA; Esa N; Sapuan S; Ong YS; Tor YS; Gopalsamy B; Voon FL; Syed Alwi SS
Biomed Res Int; 2016; 2016():4036926. PubMed ID: 27525267
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Rao CV; Seibert K
Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
